A truncated tropo-myosine-related kinase B receptor, T1, regulates glial cell morphology via rho GDP dissociation inhibitor 1

被引:97
|
作者
Ohira, K
Kumanogoh, H
Sahara, Y
Homma, KJ
Hirai, H
Nakamura, S
Hayashi, M [1 ]
机构
[1] Kyoto Univ, Inst Primate Res, Dept Cellular & Mol Biol, Inuyama, Aichi 4848506, Japan
[2] Natl Inst Neurosci, Natl Ctr Neurol & Psychiat, Dept Biochem & Cellular Biol, Tokyo 1878502, Japan
[3] Teikyo Univ, Fac Pharmaceut Sci, Dept Mol Pathol, Kanagawa 1990195, Japan
来源
JOURNAL OF NEUROSCIENCE | 2005年 / 25卷 / 06期
关键词
astrocyte; BDNF; primary culture; Rho GDI; Rho GTPase; truncated TrkB; T1;
D O I
10.1523/JNEUROSCI.4436-04.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Through tropo-myosine-related kinase B (TrkB) receptors, brain-derived neurotrophic factor ( BDNF) performs many biological functions such as neural survival, differentiation, and plasticity. T1, an isoform of TrkB receptors that lacks a tyrosine kinase, predominates in the adult mammalian CNS, yet its role remains controversial. In this study, to examine whether T1 transduces a signal and to determine its function, we first performed an affinity purification of T1-binding protein with the T1- specific C-terminal peptide and identified Rho GDP dissociation inhibitor 1 ( GDI1), a GDP dissociation inhibitor of Rho small G-proteins, as a signaling protein directly associated with T1. The binding of BDNF to T1 caused Rho GDI1 to dissociate from the C-terminal tail of T1. Astrocytes cultured for 30 d expressed only endogenous T1 among the BDNF receptors. In 30 d cultured astrocytes, Rho GDI1, when dissociated in a BDNF-dependent manner, controlled the activities of the Rho GTPases, which resulted in rapid changes in astrocytic morphology. Furthermore, using 2 d cultured astrocytes that were transfected with T1, a T1 deletion mutant, or cyan fluorescent protein fusion protein of the T1- specific C-terminal sequence, we demonstrated that T1- Rho GDI1 signaling was indispensable for regulating the activities of Rho GTPases and for the subsequent morphological changes among astrocytes. Therefore, these findings indicate that the T1 signaling cascade can alter astrocytic morphology via regulation of Rho GTPase activity.
引用
收藏
页码:1343 / 1353
页数:11
相关论文
共 12 条
  • [1] The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase
    Genot, EM
    Arrieumerlou, C
    Ku, G
    Burgering, BMT
    Weiss, A
    Kramer, IM
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (15) : 5469 - 5478
  • [2] Rho-GDP-dissociation inhibitor-γ negatively regulates NF-ΚB signaling by promoting the degradation of TAK1 in miiuy croaker (Miichthys miiuy)
    Zhou, Ming
    Ren, Xiaomeng
    Yan, Xiaolong
    Sun, Yuena
    Xu, Tianjun
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2022, 135
  • [3] HPK1 is a Ste20-related protein kinase that negatively regulates T-cell receptor-induced AP-1 activation
    Lieu, J
    Kiefer, F
    Weiss, A
    FASEB JOURNAL, 1999, 13 (07): : A1490 - A1490
  • [4] Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-κB activation
    Tuosto, L
    Costanzo, A
    Guido, F
    Marinari, B
    Vossio, S
    Moretti, F
    Levrero, M
    Piccolella, E
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (09) : 2445 - 2454
  • [5] Protein Kinase C-δ Negatively Regulates T Cell Receptor-induced NF-κB Activation by Inhibiting the Assembly of CARMA1 Signalosome
    Liu, Yu
    Song, Ren
    Gao, Yan
    Li, Yi
    Wang, Shuai
    Liu, Hai-Yun
    Wang, Yan
    Hu, Yun-Hong
    Shu, Hong-Bing
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (24) : 20081 - 20087
  • [6] The TGFβ Type I Receptor Kinase Inhibitor Vactosertib Improves T-Cell Fitness in Relapsed/Refractory Multiple Myeloma: A Phase 1b Trial
    Malek, Ehsan
    Ignatz-Hoover, James J.
    Rana, Priyanka S.
    Driscoll Ii, James J.
    BLOOD, 2024, 144 : 7042 - 7042
  • [7] B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase
    Hinman, Rochelle M.
    Bushanam, Jessica N.
    Nichols, Whitney A.
    Satterthwaite, Anne B.
    JOURNAL OF IMMUNOLOGY, 2007, 178 (02): : 740 - 747
  • [8] Vactosertib, a Novel TGFb Type I Receptor Kinase Inhibitor, Improves T-Cell Fitness:a Single-Arm, Phase 1b Trial in Relapsed/Refractory Multiple Myeloma
    Malek, Esan
    Rana, Priyanka S.
    Swamydas, Muthulekha
    Daunov, Michael
    Miyagi, Masaru
    Murphy, Elena
    Ignatz-Hoover, James J.
    Metheny, Leland
    Kim, Seong-Jin
    James, Driscoll J., II
    BLOOD, 2023, 142
  • [9] Serum/glucocorticoid-regulated kinase 1-targeted transient receptor potential oxalate subtype 1 regulates bladder smooth muscle cell proliferation due to bladder outlet obstruction in mice via activated T cell nuclear factor transcription factor 2
    He, Jiangshu
    Yang, Jin
    Chen, Lin
    He, Pinglin
    Liu, Xun
    Wang, Kai
    Dong, Taotao
    Li, Jia
    Ma, Xudong
    Bastian, Amend
    Arnulf, Stenzl
    IUBMB LIFE, 2022, 74 (05) : 463 - 473
  • [10] Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-κB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IκBα kinase activation
    Sung, Bokyung
    Pandey, Manoj K.
    Aggarwal, Bharat B.
    MOLECULAR PHARMACOLOGY, 2007, 71 (06) : 1703 - 1714